CDXS Stock - Codexis Inc.

CDXS Stock Chart

CDXS Profile

Codexis, Inc. specializes in the discovery, development, and commercialization of enzymes and other proteins that enable efficient and sustainable chemical processes. The company's innovative biocatalyst products and services are pivotal in advancing various industries, including pharmaceuticals, chemicals, and diagnostics.

At the core of Codexis' offerings is its proprietary CodeEvolver® protein engineering platform. This technology facilitates the development of biocatalysts capable of performing complex chemical transformations, thereby improving manufacturing efficiency and reducing environmental impact. Codexis also provides biocatalyst screening services and protein engineering solutions tailored to meet specific customer needs.

In addition to its industrial applications, Codexis leverages its platform for drug discovery efforts aimed at developing biotherapeutic candidates targeting human diseases. The company collaborates closely with pharmaceutical manufacturers across the United States and Europe, delivering customized solutions that enhance productivity and enable more sustainable production processes. Founded in 2002 and headquartered in Redwood City, California, Codexis continues to innovate at the intersection of biology and chemistry, driving advancements in both industrial biotechnology and therapeutic development.

CDXS Revenue Chart

CDXS Earnings

Analyst Ratings